Publication: Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel
No Thumbnail Available
Date
2014-08-01T00:00:00Z
Institution Authors
Authors
Sumbul, Ahmet Taner
ÖZYILKAN, ÖZGÜR
Sezer, Ahmet
Abali, Huseyin
Kose, Fatih
Gultepe, Ilhami
Mertsoylu, Huseyin
Muallaoglu, Sadik
Journal Title
Journal ISSN
Volume Title
Publisher
Metrikler
Abstract
The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammatory response and evidences for the relationship between NLR and the response to treatment gradually increases in cancer patients. In this study, we aimed to investigate the effect of the pretreatment NLR and other factors related to the patient on predicting the outcome of docetaxel + prednisone chemotherapy in prostate cancer patients who become castration resistant.
Description
Keywords
Citation
Sumbul A. T. , Sezer A., Abali H., Kose F., Gultepe I., Mertsoylu H., Muallaoglu S., ÖZYILKAN Ö., -Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel-, INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.46, ss.1531-1535, 2014